Document mLDLoneOLzzRkO1K8pLw07BQ

PAGE 1 MATERIAL SAFETY DATA SHEET CIBA-GEIGY CORPORATION ADDITIVES DIVISION SEVEN SKYLINE DRIVE HAWTHORNE, NEW YORK 10532 (919) 785-2000 1 1 EMERGENCY PHONE NUMBER: 1 I (800) 888-8372 1 1 1 SECTION I-IDENTITY INFORMATION IDENTITY (TRADENAME)i IRGANOX 15^0 DR FAMILY/CHEMICAL NAME: 2-METHYL-9,6-BI5{(OCTYLTHI0)METHYL}PHENOL BLEND PRODUCT TYPE: STABILIZER IMPORTANT: XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX x THIS MATERIAL IS NOT INTENDED FOR USE IN PRODUCTS FOR X x WHICH PROLONGED CONTACT WITH MUCOUS MEMBRANES OR ABRAD- X x ED SKIN, OR IMPLANTATION WITHIN THE HUMAN BODY, IS X X SPECIFICALLY INTENDED, UNLESS THE FINISHED PRODUCT HAS x x BEEN TESTED IN ACCORDANCE WITH THE FOOD AND DRUG ADMIN- x x I STRATI ON AND/OR OTHER APPLICABLE SAFETY TESTING RE- x x QUIREMENTS. BECAUSE OF THE WIDE RANGE OF SUCH POTEN- X x TIAL USES, CIBA-GEIGY CORPORATION IS NOT ABLE TO RECOM- x x MEND THIS MATERIAL AS SAFE AND EFFECTIVE FOR SUCH USES X x AND ASSUMES NO LIABILITY FOR ANY SUCH USES. x xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx THE ABOVE DISCLAIMER HAS BEEN REVISED. HAZARD STATEMENT : XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX x THIS MATERIAL SAFETY DATA SHEET CMSDS) HAS BEEN x X PREPARED IN COMPLIANCE WITH THE FEDERAL OSHA HAZARD X x COMMUNICATION STANDARD 29 CFR 1910.1200. x x THIS PRODUCT IS CONSIDERED TO BE A HAZARDOUS X x CHEMICAL UNDER THAT STANDARD. x xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx __________________ SECTION II-HAZARDOUS INGREDIENTS _________________ IRGANOX 1520 DR DO 085358 CONFIDENTIAL PAGE 2 SPECIFIC CHEMICAL NAME: 2-METHYL-A,6-BIS{(OCTYLTH101METHYL)PHENOL CAS *: 110553-27-0 COMMON NAME: IRGANOX 1520 EXPOSURE LIMITS: OSHA PEL: NONE ESTABLISHED ACGIH TLV: NONE ESTABLISHED CARCINOGENICITY: THIS CHEMICAL HAS NOT BEEN REVIEWED FOR CARCINOGENICITY BY NTP, IARC, OR OSHA. SECTION III-PHYSICAL DATA APPEARANCE: YELLOWISH OIL. ODOR; NO DISCERNABLE ODOR. BOILING POINT: >20 OC MELTING POINT: NOT DETERMINED. EVAPORATION RATE: NOT APPLICABLE. PERCENT VOLATILE: NEGLIGIBLE. VAPOR DENSITY: NOT APPLICABLE. VAPOR PRESSURE: APPROX. 0.1 MM HG AT 20C SOLUBILITY IN WATER: AT 20C, INSOLUBLE SPECIFIC GRAVITY: APPROX. 0.95 CH20 = 1) VISCOSITY: NOT DETERMINED. SECTION IV-FIRE AND EXPLOSION HAZARD DATA FLASH POINT: >350F (PENSKY-MARTENS) FLAMMABLE LIMITS IN AIR-LOWER: NOT DETERMINED. FLAMMABLE LIMITS IN AIR-UPPER: NOT DETERMINED. NFPA CODE: HI FI RO EXTINGUISHING MEDIA: CARBON DIOXIDE, FOAM, DRY CHEMICAL, WATER FOAM MAY CAUSE FROTHING. FIRE FIGHTING PROCEDURES-SPECIAL: USE SELF-CONTAINED BREATHING APPARATUS. UNUSUAL FIRE AND EXPLOSION HAZARDS: SPRAY. WATER OR IRGANOX 1520 DR DO 085359 CONFTDFNTIAl. PAGE 3 DECOMPOSITION AND COMBUSTION PRODUCTS MAY BE TOXIC. ___________________ SECTION V-REACTIVITY DATA _____________ STABILITY! STABLE. INCOMPATIBILITY: STRONG OXIDIZING AGENTS. HAZARDOUS DECOMPOSITION PRODUCTS: THERMAL DECOMPOSITION AND BURNING MAY PRODUCE CARBON MONOX IDE. CARBON DIOXIDE, SULFUR OXIDES AND POSSIBLY OTHER TOXIC SPECIES. HAZARDOUS POLYMERIZATION: HILL NOT OCCUR. SECTION VI-HEALTH HAZARD DATA PRIMARY ROUTES OF EXPOSURE: DERMAL. ORAL LD50: (RATS) >5000 MG/KG. DERMAL LD50: (RATS) >2000 MG/KG. SKIN IRRITATION: (RABBITS) NOT AN IRRITANT. EYE IRRITATION: (RABBITS) NOT AN IRRITANT. SENSITIZATION: (GUINEA PIGS) SKIN SENSITIZATION IN MAXIMIZATION TEST.(7/20 AT FIRST CHALLENGE, 1/20 AT SECOND CHALLENGE), FOR IRGANOX 1520 TERATOGENICITY: A TERATOLOGY STUDY WAS PERFORMED WITH IRGANOX 1520 IN RATS WHICH RECEIVED ORAL DOSES OF 0, 50, 150 OR 300 MG/KG/DAY DURING DAYS 6 - 15 OF GESTATION. WHILE 300 MG/KG WAS SLIGHTLY TOXIC TO THE MOTHERS, THERE WERE NO SIGNIFICANT EFFECTS ON PREGNANCY OR EMBRYO/FETAL DEVELOPMENT. MUTAGENICITY: FOR IRGANOX 1520: AMES TEST: N0N-MUTAGEN1C MICRONUCLEUS TEST: NON-MUTAGENIC CHINESE HAMSTER CELLS (V79): NON-MUTAGENIC CHROMOSOME ABERRATION (CHO CELLS IN VITRO): NON-MUTAGENIC SUBCHRONIC.ORAL FEEDING STUDIES: DURING A 28-DAY ORAL ADMINISTRATION STUDY WITH IRGANOX 1520 IN RATS, AN APPARENT FUNCTIONAL ADAPTATION OF THE LIVER OCCURRED IN ANIMALS RECEIVING 250 AND 1000 MG/KG BODY WEIGHT PER DAY. THE EFFECTS INCLUDED A LIMITED INCREASE IN LIVER WEIGHT (APPROX IMATELY 15x) AND SERUM ALKALINE PHOSPHATASE (APPROXIMATELY 30X) WITHOUT ANY SIGNS OF LIVER LESIONS. THE NO-OBSERVABLEEFFECT-LEVEL (NOEL) FOR THESE EFFECTS WAS 50 MG/KG. A 90-DAY ORAL GAVAGE STUDY WAS CONDUCTED IN THE RAT USING DDSES OF 0, 10, 100 AND 1000 MG/KG/DAY. EFFECTS INCLUDED HYPERSALI VATION AND INCREASED LIVER WEIGHT WITHOUT HISTOPATHOLOGIC IRGANOX 1520 DR Do0^ENt1t>' C PAGE A CHANGES. THE NOAEL IS CONSIDERED TO BE 1000 MG/KG/DAY WITH THE NOEL EQUAL TO 10 MG/KG/DAY. A 14-DAY RANGE-FINDING STUDY WAS CONDUCTED WITH IRGANOX 1520 USING THE BEAGLE DOG. THE NOEL IS 2000 MG/KG/DAY; HIGHER DOSAGES WERE NOT USED. ORAL ADMINISTRATION OF IRGANOX 1520 TO DOGS AT DOSE LEVELS OF 10, 100 OR 1000 MG/KG/DAY FOR THIRTEEN WEEKS WAS FOUND TO CAUSE BILIARY CELL PROLIFERATION AT THE 1000 MG/KG DOSE LEVEL THAT WAS NOT REVERSED BY 4-WEEKS, POST-DOSE. A SLIGHT TO MODERATE INCREASE IN AMINOTRANSFERASES AND/OR ALKALINE PHOSPHATASE ACTIVITIES WERE RECORDED AT THE 100 AND 1000 MG/KG DOSE LEVELS. THE NO-OBSERVABLE-EFFECT LEVEL (NOEL) WAS DETERMINED TO BE 10 MG/KG. SIGNS AND SYMPTOMS OF EXPOSURE: MAY CAUSE SKIN SENSITIZATION WHICH COULD BE SEEN AS REDNESS. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: ALLERGY, ECZEMA. EMERGENCY AND FIRST AID PROCEDURES-EYES: FOR EYE CONTACT, FLU5H EYES WITH PLENTY OF WATER FOR SEVERAL MINUTES. GET MEDICAL ATTENTION IF IRRITATION OCCURS. EMERGENCY AND FIRST AID PROCEDURES-SKIN: FOR SKIN CONTACT, WASH AFFECTED AREAS WITH PLENTY OF WATER, AND SOAP, IF AVAILABLE, FOR SEVERAL MINUTES. GET MEDICAL ATTENTION IF IRRITATION OCCURS. EMERGENCY AND FIRST AID PROCEDURES-INGESTION: IF SWALLOWED, GIVE AT LEAST 3-4 GLASSES OF WATER BUT DO NOT INDUCE VOMITING. DO NOT GIVE ANYTHING BY MOUTH TO AN UN CONSCIOUS OR CONVULSING PERSON. EMERGENCY AND FIR5T AID PROCEDURES-INHALATION: IF INHALED, REMOVE FROM AREA TO FRESH AIR. GET MEDICAL ATTENTION IF RESPIRATORY IRRITATION DEVELOPS OR IF BREATHING BECOMES DIFFICULT. EMERGENCY AND FIRST AID PRQCEDURE5-0THER: REMOVE AND WASH CONTAMINATED CLOTHING PRIOR TO REUSE. SECTION VII-SPILL OR LEAK PROCEDURES SPILL PROCEDURES: ABSORB ONTO SAND OR OTHER ABSORBENT MATERIAL. SHOVEL INTO. CLOSABLE CONTAINER FOR DISPOSAL. WEAR PROTECTIVE EQUIPMENT SPECIFIED BELOW. FLUSH RESIDUE WELL WITH DETERGENT SOLUTION. WASTE DISPOSAL METHODS: INCINERATE IN A CHEMICAL INCINERATOR EQUIPPED WITH AN AFTER BURNER AND SCRUBBER. FOLLOW ALL FEDERAL, STATE AND LOCAL REGULATIONS. EFFLUENT DATA-BOD: NOT BIODEGRADABLE IN MODIFIED STURM TEST, FOR IRGANOX 1520 EFFLUENT DATA-COD: 2.66 G COD/G SEWAGE BACTERIAL TOXICITY: INHIBITORY CONCENTRATION ON RESPIRATION OF AEROBIC WASTE WATER BACTERIA: IC20, IC50, IC80 >100 PPM IRGANOX 1520 DR 00 085361 OONFTDFNTrAI... PAGE 5 FISH TOXICITY; ZEBRA FISH, ACUTE 96 HOUR LC50: >100 PPM. INVERTEBRATE TOXICITY: DAPHNIA MAGNA, ACUTE 29 HOUR EC50: COULD NOT BE CALCULATED; ECO IS < 0.5 PPM AND EC100 IS >5.5 PPM, FOR IRGANOX 1520 SECTION VIII-SPECIAL PROTECTION INFORMATION _ VENTILATION: WORK IN WELL VENTILATED AREAS. PROTECTIVE GLOVES: WEAR IMPERVIOUS GLOVES. EYE PROTECTION: WEAR SAFETY GLASSES OR GOGGLES IF EYE CONTACT IS POSSIBLE. RESPIRATORY PROTECTION: WEAR A NIOSH APPROVED RESPIRATOR FOR ORGANIC VAPORS TO MITIGATE EXPOSURE SHOULD VAPORS OR AEROSOLS BE GENERATED DURING EXTRUSION PROCESSING OPERATIONS. CThER PROTECTIVE EQUIPMENT: WEAR APPROPRIATE PROTECTIVE EQUIPMENT TO AVOID PERSONAL CONTACT AND EXPOSURE. SECTION IX-SPECIAL PRECAUTIONS HANDLING PRECAUTIONS: MAY CAUSE ALLERGIC SKIN REACTIONS ON PROLONGED OR REPEATED CONTACT. Du NOT GET IN EYES, ON SKIN OR ON CLOTHING. DO NOT INHALE MISTS. USE ONLY WITH ADEQUATE VENTILATION. FOR INDUSTRIAL USE ONLY. SHIFFING AND STORING PRECAUTIONS: KEEP CONTAINER TIGHTLY CLOSED WHEN NOT IN USE AND DURING TRANSPORT . PERSONAL HYGIENE: WASH THOROUGHLY AFTER HANDLING AND BEFORE EATING, DRINKING, OR USING TOBACCO PRODUCTS. SECTION X- REGULATORY INFORMATION DOT PROPER SHIPPING NAME: NOT REGULATED AS A HAZARDOUS MATERIAL BY THE U.S. DEPT. OF TRANSPORTATION CDOT) 99 CFR 172.101 HAZARDOUS MATERIALS TABLE. DOT CLASS: NONE. DOT NUMBER: NONE. RCRA STATUS: NOT A HAZARDOUS WASTE UNDER RCRA (90 CFR 261). SARA/TITLE III - EHS LIST: THIS PRODUCT DOES NOT CONTAIN AN 'EXTREMELY HAZARDOUS SUB STANCE* (EHS) FOR EMERGENCY PLANNING UNDER SEC. 301-303 (90 CFR 300 AND 355) AND FOR EMERGENCY RELEASE NOTIFICATION IRGANOX 1520 DR 00 08536? conftdfnttai. PAGE 6 UNDER SEC. 304. SARA/TITLE III - CERCLA LIST: THIS PRODUCT DOES NOT CONTAIN A 'CERCLA* LISTED HAZARDOUS SUBSTANCE FOR EMERGENCY RELEASE NOTIFICATION UNDER SEC. 304 (40 CFR 302). SARA/TITLE III - OSHA/HCS HAZARDOUS CHEMICAL: THIS PRODUCT IS CONSIDERED HAZARDOUS UNDER THE OSHA 'HAZARD COMMUNICATION STANDARD' CHCS) AND IS REGULATED UNDER SEC. 511-312 (40 CFR 370). ITS HAZARDS ARE: IMMEDIATE (ACUTE) HEALTH HAZARD. SARA/TITLE III - TOXIC CHEMICALS LIST: THIS PRODUCT DOES NOT CONTAIN A TOXIC CHEMICAL FOR ROUTINE ANNUAL 'TOXIC CHEMICAL RELEASE REPORTING' UNDER SEC. 313 (40 CFR 372) . T5CA INVENTORY STATUS: CHEMICAL COMPONENTS LISTED ON TSCA INVENTORY. CALIFORNIA PROPOSITION 65: THIS PRODUCT DOES NOT CONTAIN ANY CHEMICALS CURRENTLY ON THE CALIFORNIA LIST OF KNOWN CARCINOGENS AND REPRODUCTIVE TOXINS. MASSACHUSETTS RIGHT-TO-KNOW ACT: CONTAINS NO COMPONENTS ON THE MASSACHUSETTS LIST AT A THRESHOLD LEVEL. NEW JERSEY RIGHT-TO-KNOW LABELING INFORMATION: CONTAINS THE FOLLOWING: CHEMICAL NAME = 2-METHYL-4,6-B1S((OCTYLTHIO)METHYL>PHENOL CAS NUMBER : 110553-27-0 XXX CHEMICAL NAME : EPOXIDIZED SOYBEAN OIL CAS NUMBER : 8013-07-8 ** PENNSYLVANIA RIGHT-TO-KNOW ACT: THE FOLLOWING IS REQUIRED COMPOSITION INFORMATION. CHEMICAL NAME CAS NUMBER COMMON NAME COMMENTS CHEMICAL NAME CAS NUMBER COMMENTS 2-METHYL-4,6-BIS((OCTYLTHIO)METHYL)PHENOL 110553-27-0 NONE NOT ON PENNSYLVANIA HAZARDOUS SUBSTANCE LIST. *X EPOXIDIZED SOYBEAN OIL 8013-07-8 NOT ON PENNSYLVANIA HAZARDOUS SUBSTANCE LIST. XXX ISSUE DATE: 05/14/91 REVISION: 01C FOR FURTHER INFORMATION, PLEASE CONTACT: BRUCE SCHWEMMER THE INFORMATION AND RECOMMENDATIONS CONTAINED HEREIN ARE BASED UPON DATA BELIEVED TO BE CORRECT. HOWEVER, NO GUARANTEE OR WARRANTY OF ANY KIND EXPRESSED OR IMPLIED IS MADE WITH RESPECT TO THE INFORMATION CONTAINED HEREIN. IRGANOX 1520 DR DO 085363 CONFIDENTIAL